Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for ORINF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 2.142B
March 31, 2026 2.396B
December 31, 2025 2.376B
September 30, 2025 2.054B
June 30, 2025 1.932B
March 31, 2025 1.838B
December 31, 2024 1.694B
September 30, 2024 1.794B
June 30, 2024 1.562B
March 31, 2024 1.578B
December 31, 2023 1.598B
September 30, 2023 1.453B
June 30, 2023 1.427B
March 31, 2023 1.404B
December 31, 2022 1.605B
September 30, 2022 1.536B
June 30, 2022 1.329B
March 31, 2022 1.363B
December 31, 2021 1.267B
September 30, 2021 1.224B
June 30, 2021 1.235B
March 31, 2021 1.393B
December 31, 2020 1.365B
September 30, 2020 1.290B
June 30, 2020 1.243B
Date Value
March 31, 2020 1.365B
December 31, 2019 1.163B
September 30, 2019 1.016B
June 30, 2019 1.023B
March 31, 2019 1.347B
December 31, 2018 1.311B
September 30, 2018 1.265B
June 30, 2018 1.253B
March 31, 2018 1.250B
December 31, 2017 1.267B
September 30, 2017 1.147B
June 30, 2017 1.081B
March 31, 2017 1.002B
December 31, 2016 1.121B
September 30, 2016 1.122B
June 30, 2016 1.040B
March 31, 2016 1.240B
December 31, 2015 1.138B
September 30, 2015 1.087B
June 30, 2015 1.052B
March 31, 2015 1.150B
December 31, 2014 1.212B
September 30, 2014 1.217B
June 30, 2014 1.291B
March 31, 2014 1.415B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 114.02B
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M
Veru, Inc. 37.03M
Avadel Pharmaceuticals Plc 199.45M

Total Assets (Quarterly) Related Metrics